Strikingly, the rescue of EGR1 protein could revert the phenotype originally observed in Jurkat-miR-181a-overexpressing cells, suggesting that miR-181a behaved as an oncomiR in T-ALL by downregulating EGR1. Here, EGR1 is linked to acute lymphoblastic leukemia.